Clinical Interest for Patients
My clinical and research interests include a focus on precision oncology in the management of patients with lung cancers. I am particularly interested in novel biomarker development, management of patients with oncogene driven cancer (such as ALK, ROS1, EGFR, MET, etc.) and understanding mechanisms of acquired resistance.
I believe that there is no one-size fits all approach in medicine, especially in cancer therapy. I strive to use the best scientific principles available and tailor these to the individual needs and circumstances of each patient.
- Hematology and Oncology ( 2020 )
- Internal Medicine ( 2016 )
Conditions & Treatments
Cancer Medicine, Lung Cancer
I am interested in targeted therapies and novel biomarkers. My true passion outside of medicine is classical piano performance. I also dabble with sketch comedy, film, and skiing on the side.
MD, Keck School of Medicine of the University of Southern California (2013)
BA, University of Pennsylvania (Philadelphia, PA) (2007)
University of Colorado (2013)
University of Colorado (2016)
University of Colorado (2020)
American Association of Cancer Research (AACR), Member
American College of Physicians (ACP), Member
American Medical Association (AMA), Member
American Society of Clinical Oncology (ASCO), Member
European Society for Clinical Oncology (ESMO), Member
International Association for the Study of Lung Cancer (IASLC), Member
National Comprehensive Cancer Network (NCCN), Member
Rocky Mountain Cancer Society, President Elect
Patterns of relapse in stage III NSCLC treated with curative intent and the utility of serum tumors markers in the surveillance setting (2019)
Personalized medicine models and linked electronic database to assess racial and socioeconomic disparities among patients with lung cancer in Colorado (2020)